Effects of Milk Protein Intake in Young Children on Early Growth and Later Obesity Risk: a Multicentre Randomized Clinical Trial
The Toddler Milk Intervention Trial (ToMI), sponsored by Société des Produits Nestlé, aims to evaluate the impact of varying protein content in young-child formulas on growth and obesity risk in children aged 11.5 to 13.5 months. Given the increasing global concern over childhood obesity, this trial addresses a significant market need for nutritional products that promote healthy growth. The results could enhance Nestlé's portfolio in pediatric nutrition, potentially leading to competitive advantages in the infant formula market. The study's completion in 2024 positions Nestlé to leverage findings for product development and marketing strategies targeting health-conscious parents. The trial's multicenter design across Germany and Spain may also facilitate broader European market penetration.
Indication: Healthy
Modality: protein therapy
Target: Milk protein intake and its effects on growth and obesity risk in young children.
Sponsor: Société des Produits Nestlé (SPN)
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 10, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Milk protein intake and its effects on growth and obesity risk in young children.
View original source fields
Condition raw: Healthy
Condition normalized: Healthy
Modality raw: protein therapy
Modality normalized: protein therapy
Target raw: Milk protein intake and its effects on growth and obesity risk in young children.
Target normalized: Milk protein intake and its effects on growth and obesity risk in young children.